Specify a stock or a cryptocurrency in the search bar to get a summary
Calithera Biosciences Inc
CALACalithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California. Address: 343 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CALA
Dividend Analytics CALA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CALA
Stock Valuation CALA
Financials CALA
Results | 2019 | Dynamics |